Related Experiment Video
Updated: Jul 20, 2026
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus
Objective:
Although all the mechanisms of elimination of hepatitis C virus (HCV) by Interferon (IFN) have not been fully elucidated, the 2'-5'-oligoadenylate (2-5A) system is one of the mechanisms of the antiviral effect of IFN. Consequently, the measurement of 2'-5'-oligoadenylate synthetase (2-5AS) activity could be useful for the evaluation of IFN treatment. This retrospective study was aimed at assessing whether 2-5AS activity functions as a clinical marker of virological response to PEG-interferon-alpha2b (PEG-IFN) plus ribavirin therapy of chronic hepatitis C.
Methods:
The 32 patients included in this study had high viral loads of serum HCV-RNA of genotype 1b with chronic hepatitis C. All the patients received a regimen of PEG-IFN plus ribavirin for 48 weeks, and were then divided into two groups: one group (effective group) with undetectable serum HCV-RNA levels at 24 weeks (n = 22) of therapy, the other group (ineffective group) with persistent presence of HCV-RNA in serum at 24 weeks (n = 10). The 2-5AS activity in serum was measured 2, 8 and 12 weeks before initial administration.
Results:
The 2-5AS response ratio (measured value/measured value of baseline 2-5AS) at 2, 8 and 12 weeks after the administration in the effective group was significantly higher than that in the ineffective group.
Conclusions:
These results suggest that the ratio of 2-5AS is closely related to the antiviral effect, and that the measurement of 2-5AS response ratio may be a useful clinical parameter of virological response to PEG-IFN plus ribavirin therapy of chronic hepatitis C.
Insights
The 2-5AS response ratio can predict treatment success for chronic hepatitis C patients receiving PEG-interferon-alpha2b plus ribavirin. Higher ratios indicate a better virological response to this hepatitis C virus therapy.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- The 2-5 oligoadenylate (2-5A) system is implicated in the antiviral effects of Interferon (IFN).
- Measuring 2-5 oligoadenylate synthetase (2-5AS) activity may help evaluate Interferon treatment efficacy.
- Hepatitis C virus (HCV) elimination mechanisms by IFN are not fully understood.
Purpose of the Study:
- To assess if 2-5AS activity serves as a clinical marker for virological response.
- To evaluate the efficacy of PEG-interferon-alpha2b (PEG-IFN) plus ribavirin therapy in chronic hepatitis C.
- To determine the relationship between 2-5AS activity and treatment outcomes in HCV patients.
Main Methods:
- Retrospective study of 32 chronic hepatitis C patients with high HCV-RNA viral loads (genotype 1b).
- Patients received 48 weeks of PEG-IFN plus ribavirin therapy.
- Serum 2-5AS activity was measured at baseline and 2, 8, and 12 weeks post-administration, dividing patients into effective (undetectable HCV-RNA at 24 weeks) and ineffective groups.
Main Results:
- The 2-5AS response ratio was significantly higher in the effective treatment group compared to the ineffective group.
- This difference was observed at 2, 8, and 12 weeks after therapy initiation.
- The ratio reflects the measured 2-5AS value relative to the baseline value.
Conclusions:
- The ratio of 2-5AS activity is closely linked to the antiviral effect of PEG-IFN plus ribavirin.
- Measurement of the 2-5AS response ratio may be a valuable clinical parameter.
- This parameter can predict virological response in chronic hepatitis C patients undergoing this specific therapy.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
01:25Hepatitis
01:28Viral Hepatitis I: Introduction